Analysis of T Cell and Natural Killer (NK) Cell in Relation to Viral Infections in Pediatric Stem Cell Transplant Patients and Donors
NCT02301065 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 35
Last updated 2017-07-17
Summary
Viral infections and reactivation during pediatric allogeneic hematopoietic stem cell transplantation (HSCT) are a common occurrence and significantly contribute to post-transplant morbidity and mortality. The risk is high due to prolonged periods of immune deficiency while awaiting immune reconstitution post-transplant. Current strategies to reduce complications from viral infections include prophylactic treatment, close monitoring for viral infections and prompt treatment at the first sign of symptoms or increasing viral load. However, the most definitive treatment for viral infections remains the host's cellular defenses. Improved understanding of the immune systems response to viral infections may lead to better treatment strategies.
This study is being done to explore the relationships between T-cells and NK cells (infection fighting cells) and viral infections or reactivations in young allogeneic stem cell transplant patients. The investigators will be looking at how these cells react and function in young patients receiving allogeneic stem cell transplantation, as well as in healthy stem cell donors.
Conditions
Sponsors & Collaborators
- collaborator OTHER
-
St. Jude Children's Research Hospital
lead OTHER
Principal Investigators
-
Aimee Talleur, MD · St. Jude Children's Research Hospital
Eligibility
- Max Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-10-13
- Primary Completion
- 2017-02-06
- Completion
- 2017-02-06
Countries
- United States
Study Locations
More Related Trials
-
Unrelated Hematopoietic Stem Cell Transplantation(HSCT) for Genetic Diseases of Blood Cells
NCT00730314 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Natural History Study of Clinical and Biological Factors Determining Outcomes in Chronic Graft-Versus-Host Disease
NCT00092235 ·Status: RECRUITING
-
Donor-Derived Viral Specific T-cells (VSTs) for Prophylaxis Against Viral Infections After Allogeneic Stem Cell Transplant
NCT03883906 ·Status: COMPLETED ·Phase: PHASE2
-
C-Reactive Protein as a Predictor of Stem Cell Transplant Complications
NCT00179868 ·Status: COMPLETED
-
TCR Alpha/Beta Depletion for HSCT From Haploidentical and Unrelated Donors in the Treatment of PID
NCT02327351 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant
NCT00651716 ·Status: TERMINATED
-
Immunologic Features of Respiratory Failure in Pediatric Hematopoietic Cell Transplantation (HCT) Recipients and Pediatric Oncology Patients
NCT04355780 ·Status: COMPLETED
-
Cognitive, Academic and Psychosocial Functioning in Long-Term Survivors of Pediatric Stem Cell Transplantation
NCT01701492 ·Status: COMPLETED
-
Cytokine Assay for Early Identification of Pediatric Stem Cell Transplant Recipients
NCT01135355 ·Status: TERMINATED
-
Characteristics and Dynamics of TCR Repertoire in Patients With Hematological Malignancies After Allo-HSCT
NCT03575767 ·Status: COMPLETED
-
Toward Immune Biomarkers for Tolerance and GvHD in Humans
NCT02319226 ·Status: UNKNOWN
-
Study of the Complications Associated With Certain Stem Cell Transplants
NCT01919099 ·Status: COMPLETED
-
Immunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell Transplantation
NCT00002673 ·Status: COMPLETED ·Phase: PHASE2
-
Pilot Study of Educational Interventions in Pediatric Hematopoietic Stem Cell Donors to Increase Knowledge of Donation and Transplantation Procedures
NCT01445158 ·Status: COMPLETED
-
Prospective Study of BK Virus Disease After Allogeneic Hematopoietic-cell Transplantation: Defining BK Disease's Natural History, Clinical Spectrum, Immunology, and Outcomes
NCT03532971 ·Status: COMPLETED
-
Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation
NCT01206309 ·Status: COMPLETED
-
Preemptive Therapy With CMV-specific T Cells Infusion to Prevent Refractory CMV Infection Post Transplantation
NCT02985775 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies
NCT02579967 ·Status: RECRUITING ·Phase: PHASE2
-
Prospective Phase II Study for Assessment of Regulatory Immune Cell Populations After Allogeneic HSCT
NCT00587574 ·Status: UNKNOWN
-
Long-Term Follow-up of People Undergoing Hematopoietic Stem Cell Transplantation
NCT03000244 ·Status: RECRUITING
-
Multivirus-specific T-cell Transfer Post SCT vs AdV, CMV and EBV Infections
NCT04832607 ·Status: RECRUITING ·Phase: PHASE3
-
TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients
NCT04098445 ·Status: RECRUITING
-
Early Detection of Infectious and Noninfectious Lung Diseases Following Allogeneic Hematopoietic Stem Cell Transplantation
NCT06093867 ·Status: RECRUITING
-
Transfer of Effector Memory T Cells (Tem) Following Allogeneic Stem Cell Transplantation
NCT03836690 ·Status: UNKNOWN ·Phase: PHASE1
-
Markers of Inflammation in Hematopoietic Stem Cell Transplant
NCT00579397 ·Status: COMPLETED